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Abstract: The detection of Tr)tpunosomu crirzi kinetoplast DNA by polymerase chain reaction (PCR) amplification is a potentially 
powerful tool for the parasitological diagnosis of Chagas’ disease. We have applied this technique in a field situation in Bolivia, 
where 45 children from a primary school were subjected to serological testing, buffy coat analysis and PCR diagnosis. 26 of the 28 
serology-positive individuals were also positive by PCR. In addition, two serology-negative children gave a positive result by PCR, 
including one who was positive in the buffy coat test. These results suggest that PCR detection of T. cruzi DNA in blood can be a 
very useful complement to serology in Chagas’ disease diagnosis in Bolivia. 
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Introduction 
Chagas’ disease, caused by the parasitic proto- 
zoan Tiypaiiosoina cruzi, is an important public 
health problem in most countries of Latin Amer- 
ica. Its direct diagnosis is difficult, due to the low 
concentration of parasites in the blood of in- 
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fected persons. Because of this limitation, Cha- 
gas’ disease diagnosis relies mainly on serological 
techniques. The sensitivity of these serological 
methods is generally high, but their use presents 
two main problems. First, the existence of cross- 
reactive epitopes between í”. cluzi and other par- 
asites circulating in the same geographical area 
may lead to false-positive results [l]. Second, the 
clinical status of a patient can be unlinked to his 
humoral response, as for example during the first 
weeks of an infection (when no serological reac- 
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tion is yet observed) or after specific treatment 
(when an immune response can persist for years 
even if the treatment has been successful [2]). 
These considerations have justified tlie quest for 
a more efficient nictliod of parasite detection in 
chagasic patients. The principal technique that 
has been tested for T. cruzi detection in blood 
samples is the polymerase chain reaction (PCR). 
Two main systems, leading respectively to the 
amplification of kinetoplast minicircle DNA [3-51 
or of nuclear satellite sequences [6,7]. have been 
described. Reconstitution experiments have sug- 
gested that these techniques are potentially able 
to detect a single parasite cell in 20 ml of blood 
[4,8]. However promising, these methods have yet 
to be validated in clinical samples originating 
from different geographical regions, due to tlie 
great variations in Chagas' disease incidence and 
clinical manifestations in the Americas. One 
large-scale study has been conducted in an en- 
demic region of Brazil, showing that PCR can 
attain a high level of sensitivity in this situation 
[9]. The present work is aimed at  testing the 
efficacy of PCR diagnosis of Chagas' disease in a 
radically different situation in Bolivia. 
Materials and Methods 
Patierits and clinical samples 
The individuals examined in this study be- 
longed to two different groups. The first was 
composed of 45 children from the Mizque local- 
ity, Campero province, Cochabamba department, 
Bolivia. They were 5 to 8 years old, and were 
previously selected by a serological and parasito- 
logical (buffy coat) diagnosis for Chagas' disease 
when they were at school. The second was com- 
posed of 8 control individuals from Rio de Janeiro 
and La Paz who liad never lived in endemic 
areas. 
Ten ml of blood were collected from each 
individual, 5 ml of which were mixed immediately 
with an equal volume of 6 M guanidine HC1/0.2M 
EDTA for further processing for the PCR test 
[4]. The remaining 5 ml were used for serum 
preparation and buffy coat testing. 
Seroloby arid bilffu coat tests 
Serology was performed by indirect hemagglu- 
tination using the HEMAVE kit (Polycliaco, Ar- 
gentina), indirect immunofluorescence (IIF) and 
enzyme-linked immunosorbent assay (ELISA). A 
patient was considered serology-positive when his 
serum reacted in at least two of the three tests. 
Buffy coat testing was performed in quadrupli- 
cate and observed by 2 independent people. 
DNA preparation 
The guanidine-EDTA-blood lysates were 
heated for 15 min in boiling water in order to 
shear the minicircle molecules that constitute 
most of the kDNA into moderately-sized pieces, 
and equalise their overall concentration [8]. One 
hundred p1 was used for DNA preparation. After 
phenol-cliloroforni and chloroform extraction, the 
material was precipitated with ethanol. The pellet 
was resuspended in 50 pul of distilled water and 
stored at -20°C. All these and subsequent steps 
were performed in a laminar flow hood in a 
separate room not used for manipulation of ani- 
plified products, with dedicated micropipettes and 
filter-protected tips. 
PCR conditions 
The amplification reactions were performed in 
a volume of 75 pl using the 'hot-start' protocol 
with a solid paraffin barrier separating the Taq 
DNA polymerase from the oligonucleotides [ 101. 
The lower phase consisted of 4 pl of the 1OX 
Taq polymerase buffer (100 mM Tris-HCI, pH 
8.3; 500 mM KCI), 1.8 pl of a 10 mM dNTPs 
solution, 13.5 pul of a 25 mM MgCl, solution, 200 
ng of T. crztzi-minicircle specific primers (5'- 
AAATAATGTACGGG(T/G)GAGATGCATGA 
3' and 5' GGTTCGATTGGGGTTGGTG- 
TAATATA 3' [ll]), and water up to 40 pl, in a 
thin-walled reaction tube. An Anipliwax PCR 
Gem Bead (Perkin-Elmer) was added, melted by 
placing the tube at 80°C for 5 min, and solidified 
at room temperature. The upper phase consisted 
of 7.5 p1 of the DNA sample, 3.5 pI of 10 X Taq 
DNA polymerase reaction buffer, 2.5 U of Taq 
DNA polymerase and water up to 35 FI .  The 
PCR reaction was performed using 2 cycles at  
98°C for 1 min and 64°C for 2 min, 33 cycles at  
94°C for 1 n 
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Results and Discussion 
In the PCR assay used in this study, each 
blood sample to be tested was subjected to two 
independent DNA purifications, in order to avoid 
any problems arising from inhibition in  any par- 
ticular DNA preparation. Each PCR test in- 
cluded 5 samples in duplicate, one DNA prepara- 
tion from an individual from a non-endemic aren 
(also in duplicate), an  amplification rcaction with- 
out DNA (as a negative control) and an aniplifi- 
cation reaction with DNA from a previously cliar- 
acterised chagasic patient (as a positive control). 
Typical results are shown in Fig. 1. In this way, 
we analysed 28 blood samples from serology-posi- 
tive children living in the endemic area. Twenty- 
six of them (93%) were detected in our PCR 
assay, while only four of them had parasites de- 
tectable in buffy coat testing (Table l). A previ- 
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Fig. 1. Ethidium bromide-stained agarose gel from a PCR diagnosis experiment performed on 5 Bolivian children and o 
individual from a non-endemic area. All DNA preparations From blood samples and PCR anip1ific;itions were performed 
duplicate for each patient. Lane 1, OX174 DNA digested with HoelII; Lane 2, amplification reaction without added DNA; lane, 
and 4, amplifications from a control individual; Lanes 5 and 6 to 11 and 12, amplification products from four Bolivian children w 
positive serology; lanes 13 and 14, amplifications from a serology-negative Bolivian child. Fifteen pI of the total reaction volu~ 
(75 pl) was loaded on this gel. The arrows indicate the expected products of the minicircle DNA amplification: a 330 bp ba 








disease diagnosis [12]. The results of the present 
study extend these findings to a different geo- 
graphical area and suggest that PCR may find 
extensive applications in situations where other 
methods for parasitological diagnosis of Chagas’ 
disease are currently being used. 
Seventeen blood samples from serology-nega- 
tive children were also submitted to our PCR 
assay, and 2 of them were positive (Table 1). 
Three arguments make the possibility of this re- 
sult having occurred due to DNA contamination 
improbable. Firstly, we did not detect any con- 
tamination in S DNA preparations from control 
individuals processed in duplicate at  the same 
time as the blood samples from the Bolivian 
children, while the two serology-negative, PCR 
positive samples gave an amplification in both of 
the duplicate DNA preparations. Secondly, the 
endemic region where these children live is con- 
sidered to be an area of active transmission for 
Chagas’ disease [13]. This renders the existence 
of young individuals who are serology-negative, 
but present a detectable parasitemia, explicable 
in cases of recently acquired infections, as the 
time necessary to mount a detectable humoral 
response is estimated to be several weeks [14]. 
Finally, one of the two serology-negative, PCR- 
positive children had T. cruzi cells in his blood as 
observed in buffy coat testing (Table 1). It should 
be noted that this result is consistent with the 
observation that parasitemia levels are generally 
high in the initial acute phase of Chagas’ disease, 
when no antibody responses are‘ yet detectable 
[151. 
The high level of sensitivity and specificity of 
PCR detection of T. cruzi DNA in blood, ob- 
served in this and previous studies in an endemic 
region with very different characteristics, suggests 
that this technique will be a very valuable tool to 
study the evolution of Chagas’ disease in patients 
in different epidemiological situations. 
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